Efficacy of Inhaled Ciclesonide for Outpatient Treatment of Adolescents and Adults With Symptomatic COVID-19
JAMA Internal Medicine (2022) - Comments
doi: 10.1001/jamainternmed.2021.6759  issn: 2168-6106  pubmed: 34807241  issn: 2168-6114 

Brian M. Clemency, Renoj Varughese, Yaneicy Gonzalez-Rojas, Caryn G. Morse, Wanda Phipatanakul, David J. Koster, Michael S. Blaiss